ライフサイエンスコーパス: topical antibiotic

1 nd later as addition after 4 or more days of topical antibiotics.

2 out the use of preinjection or postinjection topical antibiotics.

3 trials comparing oral antibiotic agents with topical antibiotics.

4 vitreal injections with use of postinjection topical antibiotics.

5 ive topical, intracameral, and postoperative topical antibiotics.

6 i-infectives: -36%, 95% CI: -6% to -56%; and topical antibiotics: -18%, 95% CI: -5% to -29%).

7 e gentamicin-collagen sponge, an implantable topical antibiotic agent, is approved for surgical impla

8 global clinical trials of retapamulin, a new topical antibiotic agent.

9 ost-cataract extraction endophthalmitis than topical antibiotic alone.

10 Standard clinical practice is to prescribe a topical antibiotic, although the evidence to support thi

11 aocular lens (IOL) implant and postoperative topical antibiotic and steroid.

12 0.05% of 11565 injections) in eyes receiving topical antibiotics and 3 cases (0.02% of 17208 injectio

13 Ophthalmologists continue to choose topical antibiotics and corticosteroids more frequently

14 Ophthalmologists are choosing topical antibiotics and corticosteroids more frequently

15 years had been discontinuously treated with topical antibiotics and corticosteroids without any evid

16 acute conjunctivitis fill prescriptions for topical antibiotics and factors associated with antibiot

17 vs placebo) as addition after 2 to 3 days of topical antibiotics and later as addition after 4 or mor

18 rd protocol with intravitreal, systemic, and topical antibiotics and systemic steroids.

19 All patients were treated with topical antibiotics, and 98% were treated with topical s

20 Although topical antibiotic application continues to be a controv

21 e rapidly become the standard of care in the topical antibiotic arena.

22 scribing prophylactic intravenous, oral, and topical antibiotics as well as factors that influence su

23 effect of topical povidone-iodine 1.25% and topical antibiotics commonly available in the developing

24 Topical antibiotics decrease the duration of bacterial c

25 ine 5% alone in the absence of postinjection topical antibiotics does not appear to promote bacterial

26 Using postinjection topical antibiotic drops does not reduce the risk of end

27 Use of topical antibiotics either before or after injection doe

28 vidone-iodine 1.25% ophthalmic solution with topical antibiotics for treatment of bacterial keratitis

29 t povidone-iodine and rates with and without topical antibiotics from Diabetic Retinopathy Clinical R

30 vidone-iodine and consideration to eliminate topical antibiotics from injection procedures seems warr

31 ure-proven endophthalmitis alone, the use of topical antibiotics, given immediately or for 5 days aft

32 d endophthalmitis is greater with the use of topical antibiotics, given immediately or for 5 days aft

33 New topical antibiotics have also come to the market, provid

34 in-collagen sponge, a surgically implantable topical antibiotic, is currently approved in 54 countrie

35 in areas of the world where use of effective topical antibiotics may not be an option.

36 On bivariate analysis, the use of oral and topical antibiotics over the preceding 6 months was stro

37 % of 17208 injections) in eyes not receiving topical antibiotics (P = .17).

38 were performed (57 654 injections during the topical antibiotic period, 24 617 during the transition

39 During the 28-month topical antibiotic period, there were 28 cases of suspec

40 calculating the proportion filling 1 or more topical antibiotic prescription within 14 days of initia

41 te conjunctivitis, 198 462 (58%) filled >/=1 topical antibiotic prescriptions; 38 774 filled prescrip

42 chemicals as the most common causes: nickel, topical antibiotics, preservative chemicals, fragrances

43 Three strategies of topical antibiotic prophylaxis were used by the respecti

44 Topical antibiotics remain the best treatment for bacter

45 overage with hourly fortified broad-spectrum topical antibiotic therapy.

46 a requires systemic treatment in addition to topical antibiotic therapy.

47 topical retinoid should be used instead of a topical antibiotic to minimise the impact of resistance.

48 recent review found all commonly prescribed topical antibiotics to be equally effective.

49 ice has shown that the timely application of topical antibiotics to the skin at the tick bite site co

50 acrimal canaliculitis resistant to prolonged topical antibiotic treatment in a 65-year-old woman with

51 eutralization, signal-blocking reagents, and topical antibiotic treatment to explore the inflammatory

52 ith non-Nocardia keratitis and those with no topical antibiotic use before enrollment.

53 h non-Nocardia keratitis and those having no topical antibiotic use before the SCUT enrollment showed

54 Topical antibiotic use was associated with a trend towar

55 Topical antibiotic use was common in all regions (85.2%)

56 Topical antibiotic was not shown to add to the effective

57 Exclusion of topical antibiotics was not associated with a higher ris

58 tion was compared with a 9-month period when topical antibiotics were not prescribed.

59 A 28-month period when topical antibiotics were prescribed after intravitreal i